SILVERBACK THERAPEUTICS, INC.
Profile
Company Names
SILVERBACK THERAPEUTICS, INC.
Addresses
500 FAIRVIEW AVENUE NORTH, SUITE 600, SEATTLE, WA 98109
14075 NE 30TH PLACE, BELLEVUE, WA 98007
Phone Numbers
206-456-2900
212-739-6451
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER TECHNOLOGY
Year Incorporated:
2016
State Incorporated:
DELAWARE
Total Amount Raised:
$139,258,216.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2020-09-22
$84,999,995.00
$84,999,995.00
$0.00
Equity
5
2020-03-04
$31,754,277.00
$78,697,259.00
$46,942,982.00
Equity
4
2018-09-05
$12,499,994.00
$19,999,990.00
$7,499,996.00
Equity
3
2017-12-22
$3,749.00
$3,749.00
$0.00
2
2016-04-01
$10,000,001.00
$60,000,000.00
$49,999,999.00
Equity
1
2016-03-31
$200.00
$200.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT
HERSHBERG
DIRECTOR
SAQIB
ISLAM
DIRECTOR
SCOTT
PLATSHON
DIRECTOR
JONATHAN
ROOT
DIRECTOR
SEQUENT MEDICAL, INC.
| LUTONIX INC
| INCEPTUS NEWCO1 INC.
| ONCOMED PHARMACEUTICALS INC
| INARI MEDICAL, INC.
| OMADA HEALTH, INC.
| EFFECTOR THERAPEUTICS, INC.
| RIBON THERAPEUTICS, INC.
| ROUTE 92 MEDICAL, INC.
| AIS VGP-6, LLC
| CLEAVE BIOSCIENCES, INC.
| NUVAIRA, INC.
| HEALTHJOY, INC.
| OKAMI MEDICAL, INC.
| EDGEWISE THERAPEUTICS, INC.
| SWOOP.COM, INC
| SILVERBACK THERAPEUTICS, INC.
| EL CAMINO REAL MEDICAL, INC.
| HIGHWAY 1 MEDICAL, INC.
| CARLSMED, INC.
| SURGICAL SAFETY TECHNOLOGIES INC.
| SPARROW PHARMACEUTICALS, INC.
THILO
SCHROEDER
DIRECTOR
BLUEPRINT MEDICINES CORP
| IMAGINAB, INC.
| IDEAYA BIOSCIENCES, INC.
| REVOLUTION MEDICINES, INC.
| SILVERBACK THERAPEUTICS, INC.
| CIRCLE PHARMA, INC.
| ALTEROME THERAPEUTICS, INC.
| NEXTECH VII ONCOLOGY SCSP
| NEXTECH CROSSOVER I SCSP
| NEXTECH VII CARRY SCSP
| NEXTECH CROSSOVER I CARRY SCSP
| NEXTECH VIII SCSP
| STIPPLE BIO, INC.
LAURA
SHAWVER
EXECUTIVE OFFICER, DIRECTOR
PETER
THOMPSON
EXECUTIVE OFFICER, DIRECTOR
TRUBION PHARMACEUTICALS, INC
| RESPONSE BIOMEDICAL CORP
| TV ONE LLC
| TV ONE CAPITAL CORP.
| CODA THERAPEUTICS INC
| METHYLGENE INC.
| CARDIOXYL PHARMACEUTICALS INC
| PRONAI THERAPEUTICS INC
| EQDERIVATIVES, INC.
| ADAPTIMMUNE LTD
| CORVUS PHARMACEUTICALS, INC.
| PRINCIPIA BIOPHARMA INC.
| E-SCAPE BIO, INC.
| ALPINE IMMUNE SCIENCES, INC.
| CLEAVE BIOSCIENCES, INC.
| PMV PHARMACEUTICALS, INC.
| PREVAIL THERAPEUTICS INC.
| SYNTHORX, INC.
| ALPINE IMMUNE SCIENCES, INC.
| EDGEWISE THERAPEUTICS, INC.
| SILVERBACK THERAPEUTICS, INC.
| RECODE THERAPEUTICS, INC.
| ESCAPE BIO, INC.
| CRANIOVATION, INC.
| SPARROW PHARMACEUTICALS, INC.
| ALPHEUS MEDICAL, INC.
| GENNAO BIO, INC.
| TERREMOTO BIOSCIENCES, INC.
PETER
A.
THOMPSON
EXECUTIVE OFFICER, DIRECTOR
RESPONSE BIOMEDICAL CORP
| SILVERBACK THERAPEUTICS, INC.
| DECIBEL THERAPEUTICS, INC.
| RECODE THERAPEUTICS, INC.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED GENESIS FUND, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-09-22
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
